Skip to main content

BRIUMVI

NDC 73150-150 · TG Therapeutics, Inc.

Generic nameublituximab
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)UBLITUXIMAB
Strength150 mg/6mL
Pharmacologic classCD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
Marketing categoryBLA

Packages

73150-150-06 — 1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J2329 — Injection, ublituximab-xiiy, 1mg Medicare Part B payment limit (ASP + 6%): $72.24

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.